Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study

Karin Lövgren Bengtsson, Helena Forsblad‐d’Elia, Elisabeth Lie, +6

Arthritis Research & Therapy

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

David Bursill, William J. Taylor, Robert Terkeltaub, +76

Annals of the Rheumatic Diseases

Gout, Hyperuricemia, and Crystal‐Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout

David Bursill, William J. Taylor, Robert Terkeltaub, +53

Arthritis Care & Research

Incidence and prevalence of gout in Western Sweden

Mats Dehlin, P. Drivelegka, Valgerður Sigurðardóttir, +2

Arthritis Research & Therapy

Urate and risk of Alzheimer's disease and vascular dementia: A population‐based study

Lieke E.J.M. Scheepers, L. Jacobsson, Silke Kern, +3

Alzheimer s & Dementia

Changes in pain and insulin-like growth factor 1 in fibromyalgia during exercise: the involvement of cerebrospinal inflammatory factors and neuropeptides

Jan Bjersing, Mats Dehlin, Malin C. Erlandsson, +2

Arthritis Research & Therapy

Intra-Articular Fms-Like Tyrosine Kinase 3 Ligand Expression Is a Driving Force in Induction and Progression of Arthritis

Mats Dehlin, Maria Bokarewa, Robert Rottapel, +4

PLoS ONE

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden

Karin Lövgren Bengtsson, Helena Forsblad‐d’Elia, Elisabeth Lie, +6

Annals of the Rheumatic Diseases

Validity of gout diagnosis in Swedish primary and secondary care - a validation study

Mats Dehlin, Kalliopi Stasinopoulou, L. Jacobsson

BMC Musculoskeletal Disorders

Factors associated with initiation and persistence of urate-lowering therapy

Mats Dehlin, Emin Hoxha Ekström, Max Petzold, +3

Arthritis Research & Therapy